CD19 and breast carcinoma: The TFRC and RPLP0 identified by us have been previously reported as reference genes in other cell types, including dexamethasone-exposed breast cancer cells and CD19-positive chronic lymphocytic leukemia cells (Abruzzo et al. 2005; Majidzadeh et al. 2011).